• 

  June 16, 2026

  FDA Approves New Adjuvant Treatment Option for Patients at High Risk of Kidney Cancer Recurrence

  Dr. C H Weaver MD

• 

  January 9, 2019

  Cancer of Unknown Primary Newsletter

  Dr. C H Weaver MD

• 

  October 10, 2018

  Precision Cancer Medicine Offers Hope for Treating Rare Cancers

  Dr. C H Weaver MD

• 

  August 16, 2018

  Overview of Carcinoma of Unknown Primary

  Dr. C H Weaver MD